Uzm. Dr. Cansu Akleylek

Berufserfahrung

• 2023 - 2025Erzurum Şehir Hastanesimedipol.com.tr
• 2019 - 2022Demiroğlu Bilim Üniversitesi-Florence Nightingale Hastanesimedipol.com.tr
• 2014 - 2019Trakya Üniversitesi Tıp Fakültesimedipol.com.tr

Ausbildung

• 2022Demiroğlu Bilim Üniversitesi, Romatoloji Bilim Dalımedipol.com.tr
• 2019Trakya Üniversitesi, Fizik Tedavi ve Rehabilitasyon Anabilim Dalımedipol.com.tr
• 2014Akdeniz Üniversitesi, Tıp Fakültesimedipol.com.tr

• FachgebietRheumatologiemedipol.com.trAus der Quelle
• Abteilungsname in der QuelleRomatoloji(FTR)medipol.com.trAus der Quelle
• EinrichtungMedipol Esenler Üniversite Hastanesimedipol.com.trAus der Quelle
• Publikationen37 PublikationenOpenAlexAus der Quelle
• Sprachenİngilizcemedipol.com.trAus der Quelle
• Letzte Synchronisierung4. November 2026 20:18https://medipol.com.tr/doktorlarimiz/uzmdr-cansu-akleylekmedipol.com.tr

1. PO:10:272 Long-term outcomes and predictors of treatment response in lupus patients with severe autoimmune hemolytic anemia: results from the Turkish lupus study group

   Lupus Science & Medicine, 2026

   DOI 10.1136/lupus-2026-el.326 Frei zugänglicher VolltextQuelle: OpenAlex

2. PO:10:251 Long-term treatment outcomes in lupus-associated severe immune thrombocytopenia; data from the Turkish lupus study group

   Lupus Science & Medicine, 2026

   DOI 10.1136/lupus-2026-el.308 Quelle: OpenAlex

3. Treatment of hematologic involvement in systemic lupus erythematosus

   Ulusal Romatoloji Dergisi, 2026

   DOI 10.4274/raed.galenos.2026.22932 Quelle: OpenAlex

4. The role of shear wave elastography in predicting the development of progressive pulmonary fibrosis in patients with rheumatoid arthritis

   Irish Journal of Medical Science (1971 -), 2025

   DOI 10.1007/s11845-025-04007-1 PMID 40699284 Quelle: OpenAlex

5. Latent Tuberculosis Infection in Inflammatory Rheumatic Diseases Before Biological and Synthetic DMARD Treatment: Results from Three Rheumatology Centers in Different Regions of Türkiye

   Thoracic research and practice, 2025

   DOI 10.4274/thoracrespract.2024.24098 PMID 39930694 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

6. COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data

   Asian Pacific Journal of Tropical Medicine, 2025

   DOI 10.4103/apjtm.apjtm_253_24 Frei zugänglicher VolltextQuelle: OpenAlex

7. SERIAL QUANTIFERON-TB TEST SCREENING IN RHEUMATOLOGY PATIENTS DURING TUMOR NECROSIS FACTOR ALPHA INHIBITORS TREATMENT

   Rheumatology Quarterly, 2025

   DOI 10.4274/qrheumatol.galenos.2025.53825 Frei zugänglicher VolltextQuelle: OpenAlex

8. Venous Thromboembolism May Be Increased in the Early Phases of ANCA ‐Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR ‐ VaS Experience

   International Journal of Rheumatic Diseases, 2025

   DOI 10.1111/1756-185x.70506 PMID 41408677 Quelle: OpenAlex

9. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

   Internal and Emergency Medicine, 2024

   DOI 10.1007/s11739-024-03577-9 PMID 38553624 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

10. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2661 Quelle: OpenAlex